RecruitingNCT05656261
APOL1 Genetic Testing in African Americans
Studying REN-related autosomal dominant tubulointerstitial kidney disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Louis University
- Intervention
- Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys(genetic)
- Enrollment
- 600 target
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2019 – 2027
Study locations (1)
- SSM Health Saint Louis University Hospital, St Louis, Missouri, United States
Collaborators
Mid-America Transplant
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05656261 on ClinicalTrials.gov